Advertisement
Rapid Communication| Volume 228, P329-330, September 2018

Joint position statement on universal screening for GDM in Europe by FIGO, EBCOG and EAPM

      Abstract

      Hyperglycaemia in Pregnancy (HIP) is a global issue as it increases risks for both the mother and child. There remains considerable disparity in clinical practice and national policies for HIP screening. FIGO, EBCOG and EAPM have joined forces to address this disparity in clinical care and reduce the burden of inter-generational Non-Communicable disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Devlieger R.
        • Benhalima K.
        • Damm P.
        • Van Assche A.
        • Mathieu C.
        • Mahmood T.
        • Dunne F.
        • Bogaerts A.
        Maternal Obesity in Europe: where do we stand and how to move forward? A scientific paper commissioned by the European Board and College of Obstetrics and Gynaecology (EBCOG).
        Eur J Obstet Gynecol Reprod Biol. 2016; 201: 203-208
      1. Euro-peristat perinatal health indicators.
        2010 (Accessed 20 March 2018)
        • Kapur Anil
        • Mahmood Tahir
        • Hod Moshe
        FIGO’s response to the global challenge of hyperglycemia in pregnancy – toward a global consensus.
        Gynecol Endocrinol. 2018; 34: 1-3https://doi.org/10.1080/09513590.2017.1381682
      2. International Diabetes Federation IDF Diabetes Atlas 7th Edition. Available from: http://www.diabetesatlas.org/.

        • Kapur A.
        • Mahmood T.
        • Hod M.
        The unmet need for universal testing for hyperglycaemia in pregnancy and the FIGO guideline.
        BJOG. 2018; 125: 529-531https://doi.org/10.1111/1471-0528.14659
        • Hod M.
        • Kapur A.
        • Sacks D.A.
        • Hadar E.
        • Agarwal M.
        • Di Renzo G.C.
        • et al.
        The International Federation of gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care.
        Int J Gynaecol Obstet. 2015; 131: S173-211https://doi.org/10.1016/S0020-7292(15)30007-2
        • Metzger B.E.
        • Gabbe S.G.
        • Persson B.
        • Buchanan T.A.
        • Catalano P.A.
        • et al.
        International association of diabetes and pregnancy study groups consensus panel, international association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.
        Diabetes Care. 2010; 33: 676-682
        • Colagiuri S.
        • Falavigna M.
        • Agarwal M.M.
        • Boulvain M.
        • Coetzee E.
        • Hod M.
        • et al.
        Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy.
        Diabetes Res Clin Pract. 2014; 103: 364-372
        • Jiwani A.
        • Marseille E.
        • Lohse N.
        • Damm P.
        • Hod M.
        • Kahn J.G.
        Gestational diabetes mellitus: results from a survey of country prevalence and practices.
        J Matern Fetal Neonatal Med. 2012; 25: 600-610
        • Moses R.G.
        • Cheung N.W.
        Point: universal screening for gestational diabetes mellitus.
        Diabetes Care. 2009; 32: 1349-1351
        • Simmons D.
        • Moses R.G.
        Gestational diabetes mellitus: to screen or not to screen? Is this really still a question?.
        Diabetes Care. 2013; 36: 2877-2878
        • Agarwal M.M.
        • Dhatt G.S.
        • Shah S.M.
        Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose.
        Diabetes Care. 2010; 33: 2018-2020
        • Zhu W.W.
        • Fan L.
        • Yang H.X.
        • Kong L.Y.
        • Su S.P.
        • Wang Z.L.
        • et al.
        Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China.
        Diabetes Care. 2013; 36: 2038-2040
        • Benhalima K.
        • Mathieu C.
        • Van Assche A.
        • Damm P.
        • Devlieger R.
        • Mahmood T.
        • et al.
        Survey by the European board and college of obstetrics and gynaecology on screening for gestational diabetes in Europe.
        Eur J Obstet Gynecol Reprod Biol. 2016; 201 (Epub 2016 Apr 11.): 197-202https://doi.org/10.1016/j.ejogrb.2016.04.003
        • Benhalima K.
        • Damm P.
        • Van Assche A.
        • Mathieu C.
        • Devlieger R.
        • Mahmood T.
        • et al.
        Screening for gestational diabetes in Europe: where do we stand and how to move forward?: A scientific paper commissioned by the European board & college of obstetrics and gynaecology (EBCOG).
        Eur J Obstet Gynecol Reprod Biol. 2016; 201 (Epub 2016 Apr 11): 192-196https://doi.org/10.1016/j.ejogrb.2016.04.002
      3. The Barcelona Declaration on Hyperglycemia in Pregnancy for Europe. https://www.figo.org/sites/default/files/uploads/OurWork/European%20HIP%20Declaration_February%202017.pdf. Accessed on 20 March 2018.

        • Marseille E.
        • et al.
        The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.
        J Matern Fetal Neonatal Med. 2013; 26: 802-810https://doi.org/10.3109/14767058.2013.765845
        • Kapur A.
        Is screening and integrated care for gestational diabetes cost effective?.
        J Clin Diabetol. 2015; 2